These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25766765)

  • 1. Possible involvement of CCR4+ CD8+ T cells and elevated plasma CCL22 and CCL17 in patients with rhododenol-induced leukoderma.
    Nishioka M; Tanemura A; Yang L; Tanaka A; Arase N; Katayama I
    J Dermatol Sci; 2015 Mar; 77(3):188-90. PubMed ID: 25766765
    [No Abstract]   [Full Text] [Related]  

  • 2. An immune pathological and ultrastructural skin analysis for rhododenol-induced leukoderma patients.
    Tanemura A; Yang L; Yang F; Nagata Y; Wataya-Kaneda M; Fukai K; Tsuruta D; Ohe R; Yamakawa M; Suzuki T; Katayama I
    J Dermatol Sci; 2015 Mar; 77(3):185-8. PubMed ID: 25676426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical, cytological, and immunological mechanisms of rhododendrol-induced leukoderma.
    Tokura Y; Fujiyama T; Ikeya S; Tatsuno K; Aoshima M; Kasuya A; Ito T
    J Dermatol Sci; 2015 Mar; 77(3):146-9. PubMed ID: 25726326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanocyte-specific cytotoxic T lymphocytes in patients with rhododendrol-induced leukoderma.
    Fujiyama T; Ikeya S; Ito T; Tatsuno K; Aoshima M; Kasuya A; Sakabe J; Suzuki T; Tokura Y
    J Dermatol Sci; 2015 Mar; 77(3):190-2. PubMed ID: 25724360
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoantibodies detected in patients with vitiligo vulgaris but not in those with rhododendrol-induced leukoderma.
    Arase N; Tanemura A; Jin H; Nishioka M; Aoyama Y; Oiso N; Matsunaga K; Suzuki T; Nishigori C; Kawamura T; Shimizu T; Ito A; Fukai K; Abe Y; Yang L; Tsuruta D; Takeoka K; Iwatani Y; Hidaka Y; Nishida M; Yamauchi-Takihara K; Arase H; Fujimoto M; Katayama I
    J Dermatol Sci; 2019 Aug; 95(2):80-83. PubMed ID: 31399283
    [No Abstract]   [Full Text] [Related]  

  • 6. Retention of pigment stem cells in Rhododenol-induced leukoderma: Pathological investigation of 11 patients.
    Watanabe S; Yagami A; Iwata Y; Nagai A; Kuroda M; Sugiura K; Matsunaga K
    J Dermatol; 2017 Jul; 44(7):e148-e149. PubMed ID: 28516676
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of chemokine receptor CCR4 and its ligands (CCL17 and CCL22) in murine contact hypersensitivity.
    Kusumoto M; Xu B; Shi M; Matsuyama T; Aoyama K; Takeuchi T
    J Interferon Cytokine Res; 2007 Nov; 27(11):901-10. PubMed ID: 18052724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guide for medical professionals (i.e., dermatologists) for the management of Rhododenol-induced leukoderma.
    Nishigori C; Aoyama Y; Ito A; Suzuki K; Suzuki T; Tanemura A; Ito M; Katayama I; Oiso N; Kagohashi Y; Sugiura S; Fukai K; Funasaka Y; Yamashita T; Matsunaga K
    J Dermatol; 2015 Feb; 42(2):113-28. PubMed ID: 25622988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of CCL17, CCL22 and CCR4 in drug-induced maculopapular exanthema.
    Tapia B; Morel E; Martín-Díaz MA; Díaz R; Alves-Ferreira J; Rubio P; Padial A; Bellón T
    Clin Exp Allergy; 2007 May; 37(5):704-13. PubMed ID: 17456218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Use of Topical Bimatoprost on Rhododendrol-induced Refractory Leukoderma: A Case Report.
    Fukaya S; Kamata M; Kasanuki T; Yokobori M; Takeoka S; Hayashi K; Tanaka T; Fukuyasu A; Ishikawa T; Ohnishi T; Iimuro S; Watanabe S; Tada Y
    Acta Derm Venereol; 2019 Nov; 99(12):1178-1179. PubMed ID: 31449314
    [No Abstract]   [Full Text] [Related]  

  • 11. CCR4 agonists CCL22 and CCL17 are elevated in pediatric OMS sera: rapid and selective down-regulation of CCL22 by ACTH or corticosteroids.
    Pranzatelli MR; Tate ED; McGee NR; Colliver JA; Ransohoff RM
    J Clin Immunol; 2013 May; 33(4):817-25. PubMed ID: 23340773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human memory CCR4+CD8+ T cell subset has the ability to produce multiple cytokines.
    Kondo T; Takiguchi M
    Int Immunol; 2009 May; 21(5):523-32. PubMed ID: 19261691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity.
    Scheu S; Ali S; Ruland C; Arolt V; Alferink J
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukoderma induced by rhododendrol is different from leukoderma of vitiligo in pathogenesis: A novel comparative morphological study.
    Tsutsumi R; Sugita K; Abe Y; Hozumi Y; Suzuki T; Yamada N; Yoshida Y; Yamamoto O
    J Cutan Pathol; 2019 Feb; 46(2):123-129. PubMed ID: 30456919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis.
    Yogo Y; Fujishima S; Inoue T; Saito F; Shiomi T; Yamaguchi K; Ishizaka A
    Respir Res; 2009 Aug; 10(1):80. PubMed ID: 19715610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells.
    Mariani M; Lang R; Binda E; Panina-Bordignon P; D'Ambrosio D
    Eur J Immunol; 2004 Jan; 34(1):231-40. PubMed ID: 14971049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrophotometer is useful for assessing vitiligo and chemical leukoderma severity by quantifying color difference with surrounding normally pigmented skin.
    Hayashi M; Okamura K; Araki Y; Suzuki M; Tanaka T; Abe Y; Nakano S; Yoshizawa J; Hozumi Y; Inoie M; Suzuki T
    Skin Res Technol; 2018 May; 24(2):175-179. PubMed ID: 29057565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhododendrol-induced leukoderma update II: Pathophysiology, mechanisms, risk evaluation, and possible mechanism-based treatments in comparison with vitiligo.
    Inoue S; Katayama I; Suzuki T; Tanemura A; Ito S; Abe Y; Sumikawa Y; Yoshikawa M; Suzuki K; Yagami A; Masui Y; Ito A; Matsunaga K
    J Dermatol; 2021 Jul; 48(7):969-978. PubMed ID: 33951216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the chemokine receptor CCR4 and its ligand thymus- and activation-regulated chemokine/CCL17 for lymphocyte recruitment in cutaneous lupus erythematosus.
    Wenzel J; Henze S; Wörenkämper E; Basner-Tschakarjan E; Sokolowska-Wojdylo M; Steitz J; Bieber T; Tüting T
    J Invest Dermatol; 2005 Jun; 124(6):1241-8. PubMed ID: 15955100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL17-CCR4 axis contributes to the onset of vitiligo in mice.
    Li H; Wang C; Li X; Kong Y; Sun W
    Immun Inflamm Dis; 2021 Sep; 9(3):702-709. PubMed ID: 34077992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.